Transgene's losses widen ahead of 2011 R&D results
This article was originally published in Scrip
Executive Summary
Transgene's net losses widened during 2009 as its total revenues fell and R&D costs grew. The French firm reported a net loss of €27.3 million compared with €18 million the year before.